feed,title,long_url,short_url
BioRxiv,T cell response following anti COVID-19 BNT162b2 vaccination is maintained against the SARS-CoV-2 Omicron B.1.1.529 variant of concern,https://biorxiv.org/cgi/content/short/2022.01.19.476497v1?rss=1,https://bit.ly/3GOC0cq
